Skip to main navigation Skip to search Skip to main content

Subjective well-being in patients with schizophrenia treated with atypical antipsychotics: The impact of psychopathology and adverse drug effects

  • Yeon Woo Lee
  • , Jong Hoon Kim
  • , Jun Hyung Ann
  • , Seo Eun Cho
  • , Jinyoung Lee
  • , Min Jung Kim
  • , Seong Jin Cho
  • , In Hee Cho
  • , Seog Ju Kim
  • , Yu Jin Lee
  • , Seung Min Bae
  • Gachon University

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: According to a conceptual clinical model of subjective well-being in schizophrenia, subjective well-being is viewed as the subject's perception of the outcome of an interaction between psychotic symptom severity and adverse drug effects. However, data are lacking for patients receiving atypical antipsychotics. The purpose of the present study was to evaluate the impact of psychopathology and adverse drug effects on subjective well-being in schizophrenic patients receiving atypical antipsychotics. Methods: One hundred and thirteen outpatients with schizophrenia receiving atypical antipsychotics were evaluated. Subjective well-being was assessed using the Subjective Well-being under Neuroleptics Scale (SWN). The patients' psychopathology and adverse drug effects were evaluated using the Positive and Negative Syndrome Scale (PANSS) and the Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS), respectively. Correlation analysis and multiple regression analysis were performed. Results: The SWN score had significant negative correlations with the PANSS depression/anxiety factor score and the LUNSERS scores. Multiple regression analysis revealed that depression/anxiety and akathisia contributed significantly to the SWN score. The best-fit regression model showed that these variables accounted for 29% of the total variance. Conclusion: The results of our study suggest that depressive/anxiety symptoms and akathisia contribute significantly to subjective well-being, indicating the necessity to develop strategies to control these variables effectively. These results also suggest that akathisia continues to be a major adverse effect associated with low subjective well-being in patients receiving atypical antipsychotics. Further studies are required to investigate the multidimensional predictors of subjective well-being in schizophrenia and to determine their relative contributions.

Original languageEnglish
Pages (from-to)149-155
Number of pages7
JournalClinical Psychopharmacology and Neuroscience
Volume8
Issue number3
StatePublished - Dec 2010
Externally publishedYes

Keywords

  • Akathisia
  • Atypical antipsychotics
  • Depressive symptoms
  • Schizophrenia
  • Subjective well-being

Fingerprint

Dive into the research topics of 'Subjective well-being in patients with schizophrenia treated with atypical antipsychotics: The impact of psychopathology and adverse drug effects'. Together they form a unique fingerprint.

Cite this